Cargando…
Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer
The cancer vaccine 105AD7 is an anti-idiotypic monoclonal antibody that mimics the tumour-associated antigen 791T/gp72 (CD55, Decay Accelerating Factor) on colorectal cancer cells. Phase I studies in patients with advanced disease confirmed that 105AD7 is non-toxic, and that T cell responses could b...
Autores principales: | Maxwell-Armstrong, C A, Durrant, L G, Buckley, T J D, Scholefield, J H, Robins, R A, Fielding, K, Monson, J R T, Guillou, P, Calvert, H, Carmichael, J, Hardcastle, J D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363670/ https://www.ncbi.nlm.nih.gov/pubmed/11384090 http://dx.doi.org/10.1054/bjoc.2001.1725 |
Ejemplares similares
-
Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcoma
por: Pritchard-Jones, K, et al.
Publicado: (2005) -
Enhanced recognition of human colorectal tumour cells using combinations of monoclonal antibodies.
por: Durrant, L. G., et al.
Publicado: (1989) -
CROSS-IDIOTYPIC SPECIFICITY AMONG MONOCLONAL IGM PROTEINS WITH ANTI-γ-GLOBULIN ACTIVITY
por: Kunkel, H. G., et al.
Publicado: (1973) -
Idiotypic cross-reactions of monoclonal human lupus autoantibodies
Publicado: (1983) -
Consumption of monoclonal anti-idiotypic antibody by neoplastic B lymphocytes: a guide for immunotherapy.
por: Stevenson, F. K., et al.
Publicado: (1984)